OPRX — OptimizeRx Corp

Nasdaq · Industrials · Professional Services · CIK 1448431 ·
Last close
$7.65
Market Cap
$144.10M
52W High
$9.08
52W Low
$4.54
ADV30
240,864
Next earnings
2026-11-05
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 19,844,000 14,932,000 396,000 -495,000 167,264,000 20,169,000 37,653,000
Dec 2025 32,239,000 24,100,000 8,937,000 5,020,000 176,918,000 23,365,000 48,624,000
Sep 2025 26,067,000 17,516,000 2,050,000 779,000 170,321,000 19,519,000 48,058,000
Jun 2025 29,195,000 18,635,000 3,189,000 1,532,000 169,265,000 16,585,000 49,981,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$14,384,000
Investing CF
$131,000
Financing CF
$-10,919,000
CapEx
$-159,000
Dividends Paid
Buybacks
$0
EPS Diluted TTM
$0.35
As of
2026-08-16

Balance + Analyst (yfinance extras)

Retained Earnings
$-79,731,000
Inventory
Receivables
$32,860,000
ST Investments
EBIT TTM
$14,742,000
Pretax Income TTM
$9,589,000
Interest Exp TTM
$5,153,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$98,654,000
EBITDA
$15,551,000
Free Cash Flow
$15,760,875
Enterprise Value
$139,479,024
Total Cash
$24,096,000
Total Debt
$19,480,000
Shares Out
18,835,951
Trailing EPS
$0.25
Book Value
$6.96
ROE
3.7%
ROA
4.2%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 109,429,000 12,061,000 5,132,000 176,918,000 48,624,000 18,715,000
Dec 2024 92,127,000 -6,217,000 -20,110,000 171,168,000 54,170,000 4,889,000
Dec 2023 71,522,000 -17,522,000 -17,566,000 183,374,000 56,821,000 -7,240,000
Dec 2022 62,450,156 -12,290,738 -11,438,440 134,651,185 8,540,408 10,654,078
Dec 2021

TTM Snapshot

Revenues TTM
$21,309,000
NetIncome TTM
$-9,124,000
OpCashFlow TTM
$0
Assets (Latest)
$171,168,000
Forward EPS
$1.06

Max Pain — expiry 2026-09-18

max pain strike: $7.50 · spot: $7.80 · call oi: 1,752 · put oi: 1,029
Expected Move to 2026-09-18: ±$1.00 (12.82%) — implied range $6.80$8.80 · ATM straddle on $7.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
RGP RESOURCES CONNECTION, INC. $147.42M $4.28
RYDE Ryde Group Ltd $118.24M $0.79
AMWL American Well Corp $179.53M $11.92
DHX DHI GROUP, INC. $183.25M $4.22
GETY Getty Images Holdings, Inc. $107.40M $0.26

News headlines (Yahoo Finance, 1h cache)

OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript
2026-08-19 23:44 · Yahoo
OptimizeRx Corp (OPRX) (Q2 2026) Earnings Call Highlights: Navigating Revenue Headwinds with ...
2026-08-13 05:03 · Yahoo
OptimizeRx Q2 Earnings Call Highlights
2026-08-13 01:04 · Yahoo
OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates
2026-08-12 21:40 · Yahoo
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
2026-08-12 20:05 · Yahoo
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
2026-08-12 20:01 · Yahoo
OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
2026-07-29 11:30 · Yahoo
OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer
2026-07-23 11:30 · Yahoo
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
2026-06-25 11:30 · Yahoo
OptimizeRx to Participate in Upcoming Investor Conferences
2026-06-01 11:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.